Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iohexol for measuring renal function in critically ill children
NL-OMON49710Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of iohexol in acute kidney failure (AKF), sponsored by Radboud University Medical Center. Primary endpoint: Prevalence of acute kidney injury based on iohexol plasma clearance. Started May 2019; status: active, not recruiting.
02
Drugs
iohexol
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NL-OMON49710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49710.